Search


How a new CEO has been trying to position Editas to execute on the promise of CRISPR
Gilmore O’Neill is working to inject stability and focus at Editas as it aims to execute on both ex-vivo and in-vivo crispr gene therapies.
Aug 2, 2023
Also look for unique social pages for BiotechTV U.
HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.
Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.